HCPCS codes:C

• C1300 - Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval.
• C1713 - Anchor-screw for opposing bone-to-bone or soft tissue-to-bone (implantable).
• C1714 - Catheter, transluminal atherectomy, directional.
• C1715 - Brachytherapy needle.
• C1716 - Brachytherapy source, non-stranded, gold-198, per source.
• C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source.
• C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source.
• C1721 - Cardioverter-defibrillator, dual chamber (implantable).
• C1722 - Cardioverter-defibrillator, single chamber (implantable).
• C1724 - Catheter, transluminal atherectomy, rotational.
• C1725 - Catheter, transluminal angioplasty, non-laser (may include guidance, infusion-perfusion capability).
• C1726 - Catheter, balloon dilatation, non-vascular.
• C1727 - Catheter, balloon tissue dissector, non-vascular (insertable).
• C1728 - Catheter, brachytherapy seed administration.
• C1729 - Catheter, drainage.
• C1730 - Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes).
• C1731 - Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes).
• C1732 - Catheter, electrophysiology, diagnostic-ablation, 3d or vector mapping.
• C1733 - Catheter, electrophysiology, diagnostic-ablation, other than 3d or vector mapping, other than cool-tip.
• C1749 - Endoscope, retrograde imaging-illumination colonoscope device (implantable).
• C1750 - Catheter, hemodialysis-peritoneal, long-term.
• C1751 - Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis).
• C1752 - Catheter, hemodialysis-peritoneal, short-term.
• C1753 - Catheter, intravascular ultrasound.
• C1754 - Catheter, intradiscal.
• C1755 - Catheter, intraspinal.
• C1756 - Catheter, pacing, transesophageal.
• C1757 - Catheter, thrombectomy-embolectomy.
• C1758 - Catheter, ureteral.
• C1759 - Catheter, intracardiac echocardiography.
• C1760 - Closure device, vascular (implantable-insertable).
• C1762 - Connective tissue, human (includes fascia lata).
• C1763 - Connective tissue, non-human (includes synthetic).
• C1764 - Event recorder, cardiac (implantable).
• C1765 - Adhesion barrier.
• C1766 - Introducer-sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away.
• C1767 - Generator, neurostimulator (implantable), non-rechargeable.
• C1768 - Graft, vascular.
• C1769 - Guide wire.
• C1770 - Imaging coil, magnetic resonance (insertable).
• C1771 - Repair device, urinary, incontinence, with sling graft.
• C1772 - Infusion pump, programmable (implantable).
• C1773 - Retrieval device, insertable (used to retrieve fractured medical devices).
• C1776 - Joint device (implantable).
• C1777 - Lead, cardioverter-defibrillator, endocardial single coil (implantable).
• C1778 - Lead, neurostimulator (implantable).
• C1779 - Lead, pacemaker, transvenous vdd single pass.
• C1780 - Lens, intraocular (new technology).
• C1781 - Mesh (implantable).
• C1782 - Morcellator.
• C1783 - Ocular implant, aqueous drainage assist device.
• C1784 - Ocular device, intraoperative, detached retina.
• C1785 - Pacemaker, dual chamber, rate-responsive (implantable).
• C1786 - Pacemaker, single chamber, rate-responsive (implantable).
• C1787 - Patient programmer, neurostimulator.
• C1788 - Port, indwelling (implantable).
• C1789 - Prosthesis, breast (implantable).
• C1813 - Prosthesis, penile, inflatable.
• C1814 - Retinal tamponade device, silicone oil.
• C1815 - Prosthesis, urinary sphincter (implantable).
• C1816 - Receiver and-or transmitter, neurostimulator (implantable).
• C1817 - Septal defect implant system, intracardiac.
• C1818 - Integrated keratoprosthesis.
• C1819 - Surgical tissue localization and excision device (implantable).
• C1820 - Generator, neurostimulator (implantable), with rechargeable battery and charging system.
• C1821 - Interspinous process distraction device (implantable).
• C1822 - Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system.
• C1823 - Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads.
• C1830 - Powered bone marrow biopsy needle.
• C1840 - Lens, intraocular (telescopic).
• C1841 - Retinal prosthesis, includes all internal and external components.
• C1842 - Retinal prosthesis, includes all internal and external components; add-on to c1841.
• C1874 - Stent, coated-covered, with delivery system.
• C1875 - Stent, coated-covered, without delivery system.
• C1876 - Stent, non-coated-non-covered, with delivery system.
• C1877 - Stent, non-coated-non-covered, without delivery system.
• C1878 - Material for vocal cord medialization, synthetic (implantable).
• C1880 - Vena cava filter.
• C1881 - Dialysis access system (implantable).
• C1882 - Cardioverter-defibrillator, other than single or dual chamber (implantable).
• C1883 - Adapter-extension, pacing lead or neurostimulator lead (implantable).
• C1884 - Embolization protective system.
• C1885 - Catheter, transluminal angioplasty, laser.
• C1886 - Catheter, extravascular tissue ablation, any modality (insertable).
• C1887 - Catheter, guiding (may include infusion-perfusion capability).
• C1888 - Catheter, ablation, non-cardiac, endovascular (implantable).
• C1889 - Implantable-insertable device, not otherwise classified.
• C1891 - Infusion pump, non-programmable, permanent (implantable).
• C1892 - Introducer-sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away.
• C1893 - Introducer-sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away.
• C1894 - Introducer-sheath, other than guiding, other than intracardiac electrophysiological, non-laser.
• C1895 - Lead, cardioverter-defibrillator, endocardial dual coil (implantable).
• C1896 - Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable).
• C1897 - Lead, neurostimulator test kit (implantable).
• C1898 - Lead, pacemaker, other than transvenous vdd single pass.
• C1899 - Lead, pacemaker-cardioverter-defibrillator combination (implantable).
• C1900 - Lead, left ventricular coronary venous system.
• C2613 - Lung biopsy plug with delivery system.
• C2614 - Probe, percutaneous lumbar discectomy.
• C2615 - Sealant, pulmonary, liquid.
• C2616 - Brachytherapy source, non-stranded, yttrium-90, per source.
• C2617 - Stent, non-coronary, temporary, without delivery system.
• C2618 - Probe-needle, cryoablation.
• C2619 - Pacemaker, dual chamber, non rate-responsive (implantable).
• C2620 - Pacemaker, single chamber, non rate-responsive (implantable).
• C2621 - Pacemaker, other than single or dual chamber (implantable).
• C2622 - Prosthesis, penile, non-inflatable.
• C2623 - Catheter, transluminal angioplasty, drug-coated, non-laser.
• C2624 - Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components.
• C2625 - Stent, non-coronary, temporary, with delivery system.
• C2626 - Infusion pump, non-programmable, temporary (implantable).
• C2627 - Catheter, suprapubic-cystoscopic.
• C2628 - Catheter, occlusion.
• C2629 - Introducer-sheath, other than guiding, other than intracardiac electrophysiological, laser.
• C2630 - Catheter, electrophysiology, diagnostic-ablation, other than 3d or vector mapping, cool-tip.
• C2631 - Repair device, urinary, incontinence, without sling graft.
• C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source.
• C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source.
• C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm.
• C2637 - Brachytherapy source, non-stranded, ytterbium-169, per source.
• C2638 - Brachytherapy source, stranded, iodine-125, per source.
• C2639 - Brachytherapy source, non-stranded, iodine-125, per source.
• C2640 - Brachytherapy source, stranded, palladium-103, per source.
• C2641 - Brachytherapy source, non-stranded, palladium-103, per source.
• C2642 - Brachytherapy source, stranded, cesium-131, per source.
• C2643 - Brachytherapy source, non-stranded, cesium-131, per source.
• C2644 - Brachytherapy source, cesium-131 chloride solution, per millicurie.
• C2645 - Brachytherapy planar source, palladium-103, per square millimeter.
• C2698 - Brachytherapy source, stranded, not otherwise specified, per source.
• C2699 - Brachytherapy source, non-stranded, not otherwise specified, per source.
• C5271 - Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area.
• C5272 - Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure).
• C5273 - Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children.
• C5274 - Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure).
• C5275 - Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and-or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area.
• C5276 - Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and-or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure).
• C5277 - Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and-or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children.
• C5278 - Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and-or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure).
• C8900 - Magnetic resonance angiography with contrast, abdomen.
• C8901 - Magnetic resonance angiography without contrast, abdomen.
• C8902 - Magnetic resonance angiography without contrast followed by with contrast, abdomen.
• C8903 - Magnetic resonance imaging with contrast, breast; unilateral.
• C8904 - Magnetic resonance imaging without contrast, breast; unilateral.
• C8905 - Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral.
• C8906 - Magnetic resonance imaging with contrast, breast; bilateral.
• C8907 - Magnetic resonance imaging without contrast, breast; bilateral.
• C8908 - Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral.
• C8909 - Magnetic resonance angiography with contrast, chest (excluding myocardium).
• C8910 - Magnetic resonance angiography without contrast, chest (excluding myocardium).
• C8911 - Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium).
• C8912 - Magnetic resonance angiography with contrast, lower extremity.
• C8913 - Magnetic resonance angiography without contrast, lower extremity.
• C8914 - Magnetic resonance angiography without contrast followed by with contrast, lower extremity.
• C8918 - Magnetic resonance angiography with contrast, pelvis.
• C8919 - Magnetic resonance angiography without contrast, pelvis.
• C8920 - Magnetic resonance angiography without contrast followed by with contrast, pelvis.
• C8921 - Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete.
• C8922 - Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study.
• C8923 - Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography.
• C8924 - Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study.
• C8925 - Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report.
• C8926 - Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report.
• C8927 - Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis.
• C8928 - Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and-or pharmacologically induced stress, with interpretation and report.
• C8929 - Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography.
• C8930 - Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and-or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision.
• C8931 - Magnetic resonance angiography with contrast, spinal canal and contents.
• C8932 - Magnetic resonance angiography without contrast, spinal canal and contents.
• C8933 - Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents.
• C8934 - Magnetic resonance angiography with contrast, upper extremity.
• C8935 - Magnetic resonance angiography without contrast, upper extremity.
• C8936 - Magnetic resonance angiography without contrast followed by with contrast, upper extremity.
• C8937 - Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection-characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure).
• C8957 - Intravenous infusion for therapy-diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump.
• C9014 - Injection, cerliponase alfa, 1 mg.
• C9015 - Injection, c-1 esterase inhibitor (human), haegarda, 10 units.
• C9016 - Injection, triptorelin extended release, 3.75 mg.
• C9021 - Injection, obinutuzumab, 10 mg.
• C9022 - Injection, elosulfase alfa, 1mg.
• C9023 - Injection, testosterone undecanoate, 1 mg.
• C9024 - Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine.
• C9025 - Injection, ramucirumab, 5 mg.
• C9026 - Injection, vedolizumab, 1 mg.
• C9027 - Injection, pembrolizumab, 1 mg.
• C9028 - Injection, inotuzumab ozogamicin, 0.1 mg.
• C9029 - Injection, guselkumab, 1 mg.
• C9030 - Injection, copanlisib, 1 mg.
• C9031 - Lutetium lu 177, dotatate, therapeutic, 1 mci.
• C9032 - Injection, voretigene neparvovec-rzyl, 1 billion vector genome.
• C9033 - Injection, fosnetupitant 235 mg and palonosetron 0.25 mg.
• C9034 - Injection, dexamethasone 9%, intraocular, 1 mcg.
• C9035 - Injection, aripiprazole lauroxil (aristada initio), 1 mg.
• C9036 - Injection, patisiran, 0.1 mg.
• C9037 - Injection, risperidone (perseris), 0.5 mg.
• C9038 - Injection, mogamulizumab-kpkc, 1 mg.
• C9039 - Injection, plazomicin, 5 mg.
• C9113 - Injection, pantoprazole sodium, per vial.
• C9121 - Injection, argatroban, per 5 mg.
• C9132 - Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity.
• C9133 - Factor ix (antihemophilic factor, recombinant), rixubis, per i.u..
• C9134 - Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u..
• C9135 - Factor ix (antihemophilic factor, recombinant), alprolix, per i.u..
• C9136 - Injection, factor viii, fc fusion protein, (recombinant), per i.u..
• C9137 - Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u..
• C9138 - Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u..
• C9139 - Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u..
• C9140 - Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u..
• C9248 - Injection, clevidipine butyrate, 1 mg.
• C9250 - Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml.
• C9254 - Injection, lacosamide, 1 mg.
• C9257 - Injection, bevacizumab, 0.25 mg.
• C9275 - Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose.
• C9285 - Lidocaine 70 mg-tetracaine 70 mg, per patch.
• C9290 - Injection, bupivacaine liposome, 1 mg.
• C9293 - Injection, glucarpidase, 10 units.
• C9349 - Puraply, and puraply antimicrobial, any type, per square centimeter.
• C9352 - Microporous collagen implantable tube (neuragen nerve guide), per centimeter length.
• C9353 - Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length.
• C9354 - Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter.
• C9355 - Collagen nerve cuff (neuromatrix), per 0.5 centimeter length.
• C9356 - Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter.
• C9358 - Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters.
• C9359 - Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc.
• C9360 - Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters.
• C9361 - Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length.
• C9362 - Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc.
• C9363 - Skin substitute, integra meshed bilayer wound matrix, per square centimeter.
• C9364 - Porcine implant, permacol, per square centimeter.
• C9399 - Unclassified drugs or biologicals.
• C9407 - Iodine i-131 iobenguane, diagnostic, 1 millicurie.
• C9408 - Iodine i-131 iobenguane, therapeutic, 1 millicurie.
• C9441 - Injection, ferric carboxymaltose, 1 mg.
• C9442 - Injection, belinostat, 10 mg.
• C9443 - Injection, dalbavancin, 10 mg.
• C9444 - Injection, oritavancin, 10 mg.
• C9445 - Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units.
• C9446 - Injection, tedizolid phosphate, 1 mg.
• C9447 - Injection, phenylephrine and ketorolac, 4 ml vial.
• C9448 - Netupitant 300 mg and palonosetron 0.5 mg, oral.
• C9449 - Injection, blinatumomab, 1 mcg.
• C9450 - Injection, fluocinolone acetonide intravitreal implant, 0.01 mg.
• C9451 - Injection, peramivir, 1 mg.
• C9452 - Injection, ceftolozane 50 mg and tazobactam 25 mg.
• C9453 - Injection, nivolumab, 1 mg.
• C9454 - Injection, pasireotide long acting, 1 mg.
• C9455 - Injection, siltuximab, 10 mg.
• C9456 - Injection, isavuconazonium sulfate, 1 mg.
• C9457 - Injection, sulfur hexafluoride lipid microsphere, per ml.
• C9458 - Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries.
• C9459 - Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries.
• C9460 - Injection, cangrelor, 1 mg.
• C9461 - Choline c 11, diagnostic, per study dose.
• C9462 - Injection, delafloxacin, 1 mg.
• C9463 - Injection, aprepitant, 1 mg.
• C9464 - Injection, rolapitant, 0.5 mg.
• C9465 - Hyaluronan or derivative, durolane, for intra-articular injection, per dose.
• C9466 - Injection, benralizumab, 1 mg.
• C9467 - Injection, rituximab and hyaluronidase, 10 mg.
• C9468 - Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u..
• C9469 - Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg.
• C9470 - Injection, aripiprazole lauroxil, 1 mg.
• C9471 - Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg.
• C9472 - Injection, talimogene laherparepvec, 1 million plaque forming units (pfu).
• C9473 - Injection, mepolizumab, 1 mg.
• C9474 - Injection, irinotecan liposome, 1 mg.
• C9475 - Injection, necitumumab, 1 mg.
• C9476 - Injection, daratumumab, 10 mg.
• C9477 - Injection, elotuzumab, 1 mg.
• C9478 - Injection, sebelipase alfa, 1 mg.
• C9479 - Instillation, ciprofloxacin otic suspension, 6 mg.
• C9480 - Injection, trabectedin, 0.1 mg.
• C9481 - Injection, reslizumab, 1 mg.
• C9482 - Injection, sotalol hydrochloride, 1 mg.
• C9483 - Injection, atezolizumab, 10 mg.
• C9484 - Injection, eteplirsen, 10 mg.
• C9485 - Injection, olaratumab, 10 mg.
• C9486 - Injection, granisetron extended release, 0.1 mg.
• C9487 - Ustekinumab, for intravenous injection, 1 mg.
• C9488 - Injection, conivaptan hydrochloride, 1 mg.
• C9489 - Injection, nusinersen, 0.1 mg.
• C9490 - Injection, bezlotoxumab, 10 mg.
• C9491 - Injection, avelumab, 10 mg.
• C9492 - Injection, durvalumab, 10 mg.
• C9493 - Injection, edaravone, 1 mg.
• C9494 - Injection, ocrelizumab, 1 mg.
• C9497 - Loxapine, inhalation powder, 10 mg.
• C9600 - Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch.
• C9601 - Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure).
• C9602 - Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch.
• C9603 - Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure).
• C9604 - Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel.
• C9605 - Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure).
• C9606 - Percutaneous transluminal revascularization of acute total-subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel.
• C9607 - Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel.
• C9608 - Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure).
• C9724 - Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy.
• C9725 - Placement of endorectal intracavitary applicator for high intensity brachytherapy.
• C9726 - Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure.
• C9727 - Insertion of implants into the soft palate; minimum of three implants.
• C9728 - Placement of interstitial device(s) for radiation therapy-surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple.
• C9733 - Non-ophthalmic fluorescent vascular angiography.
• C9734 - Focused ultrasound ablation-therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance.
• C9735 - Anoscopy; with directed submucosal injection(s), any substance.
• C9737 - Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band).
• C9738 - Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure).
• C9739 - Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants.
• C9740 - Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants.
• C9741 - Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report.
• C9742 - Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed.
• C9743 - Injection-implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies).
• C9744 - Ultrasound, abdominal, with contrast.
• C9745 - Nasal endoscopy, surgical; balloon dilation of eustachian tube.
• C9746 - Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and-or fluoroscopy, when performed.
• C9747 - Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance.
• C9748 - Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy.
• C9749 - Repair of nasal vestibular lateral wall stenosis with implant(s).
• C9750 - Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode).
• C9751 - Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and-or transbronchial sampling (eg, aspiration[s]-biopsy[ies]) and all mediastinal and-or hilar lymph node stations or structures and therapeutic intervention(s).
• C9752 - Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar-sacrum.
• C9753 - Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar-sacrum (list separately in addition to code for primary procedure).
• C9754 - Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed).
• C9755 - Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and-or ultrasound, with radiologic supervision and interpretation, when performed.
• C9800 - Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies.
• C9898 - Radiolabeled product provided during a hospital inpatient stay.
• C9899 - Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage.
• CA - Procedure payable only in the inpatient setting when performed emergently on an outpatient who expires prior to admission.
• CB - Service ordered by a renal dialysis facility (rdf) physician as part of the esrd beneficiary's dialysis benefit, is not part of the composite rate, and is separately reimbursable.
• CC - Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed).
• CD - Amcc test has been ordered by an esrd facility or mcp physician that is part of the composite rate and is not separately billable.
• CE - Amcc test has been ordered by an esrd facility or mcp physician that is a composite rate test but is beyond the normal frequency covered under the rate and is separately reimbursable based on medical necessity.
• CF - Amcc test has been ordered by an esrd facility or mcp physician that is not part of the composite rate and is separately billable.
• CG - Policy criteria applied.
• CH - 0 percent impaired, limited or restricted.
• CI - At least 1 percent but less than 20 percent impaired, limited or restricted.
• CJ - At least 20 percent but less than 40 percent impaired, limited or restricted.
• CK - At least 40 percent but less than 60 percent impaired, limited or restricted.
• CL - At least 60 percent but less than 80 percent impaired, limited or restricted.
• CM - At least 80 percent but less than 100 percent impaired, limited or restricted.
• CN - 100 percent impaired, limited or restricted.
• CO - Outpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant.
• CP - Adjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim.
• CQ - Outpatient physical therapy services furnished in whole or in part by a physical therapist assistant.
• CR - Catastrophe-disaster related.
• CS - Item or service related, in whole or in part, to an illness, injury, or condition that was caused by or exacerbated by the effects, direct or indirect, of the 2010 oil spill in the gulf of mexico, including but not limited to subsequent clean-up activities.
• CT - Computed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standard.

HCPCS codes
HCPCS codes starting with A - B - C - D - E - F - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

External links

• HCPCS by the AAPC
• HCPCS Complete Reference
• HCPCS Level 2 codes 2020